Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.34 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.34 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.34 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.34 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.34 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.34 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.34 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.34 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.34 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1153012 | 0.95 | ANPEP (0.39) | ANPEPHPGDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1153589 | 0.95 | ANPEP (0.39) | ANPEPHPGDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1152996 | 0.94 | ANPEP (0.38) | ANPEPHPGDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1153439 | 0.88 | CTSL (0.41) | ANPEPPSMB8PSMB5ALDH1A1CYP2D6 | |
| SCHEMBL1153709 | 0.86 | ANPEP (0.44) | ANPEPNPC1RAB9AMEN1KMT2A | |
| SCHEMBL1153715 | 0.83 | HPGD (0.36) | ANPEPHPGDNPC1MAPTRAB9A | |
| SCHEMBL4343680 | 0.83 | ANPEP (0.40) | ANPEPHPGDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1153629 | 0.83 | CTSL (0.40) | ANPEPALDH1A1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL1152498 | 0.83 | PSEN1 (0.41) | ANPEPHPGDALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL1152877 | 0.82 | ATM (0.46) | NPC1MAPTRAB9APSMB8PSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943799-B2 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-17 | — | — | US | disclosed |
| US-20110046415-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-24 | — | — | US | disclosed |
| US-7842839-B2 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-30 | — | — | US | disclosed |
| US-20070112201-A1 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-17 | — | — | US | disclosed |
| EP-1698617-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENE BISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112201-A1 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | CYP3A7, GRK7, CYP2A7 | ANPEP 2755/4885HPGD 4153/4885SLC6A2 4608/4885 |
| US-20110046415-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF | CYP3A7, GRK7, CYP2A7 | ANPEP 2755/4885HPGD 4153/4885SLC6A2 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.